Post-authorization safety study of Clottafact® , a triply secured fibrinogen concentrate in congenital afibrinogenemia. A prospective observational study.
Vox Sang
; 111(4): 383-390, 2016 Nov.
Article
in En
| MEDLINE
| ID: mdl-27583698
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Fibrinogen
/
Coagulants
/
Afibrinogenemia
Type of study:
Clinical_trials
/
Etiology_studies
/
Guideline
/
Observational_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
/
Middle aged
Language:
En
Journal:
Vox Sang
Year:
2016
Document type:
Article
Affiliation country:
Francia
Country of publication:
Reino Unido